Диссертация (1154906), страница 15
Текст из файла (страница 15)
Kosiborod M, Smith GL, Radford MJ, Foody JM, Krumholz HM. Theprognostic importance of anemia in patients with heart failure. // Am JMed.– 2003. - vol. 114(2). – p.112–119.59. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heartfailure and is associated with poor outcomes: insights from a cohort of 12065 patients with new-onset heart failure. // Circulation. – 2003. - vol.107(2). – p.223–225.60. Al-Ahmad A, Rand WM, Manjunath G, et al. Reduced kidney function andanemia as risk factors for mortality in patients with left ventriculardysfunction. // J Am Coll Cardiol.
– 2001. - vol. 38(4). – p.955–962.61. Felker GM, Benza RL, Chandler AB, Leimberger JD, Cuffe MS, Califf RM,Gheorghiade M, O’Connor CM, for the OPTIME-CHF Investigators. Heartfailure etiology and response to milrinone in decompensated heart failure:results from the OPTIME-CHF study. // J Am Coll Cardiol. – 2003. vol. 41. – p. 997–1003.9862. Szachniewicz J, Petruk-Kowalczyk J, Majda J, et al. Anaemia is anindependent predictor of poor outcome in patients with chronic heart failure.// Int J Cardiol. – 2003. - vol.
90(2–3). – p.303–308.63. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heartfailure: the prospective randomized amlodipine survival evaluation(PRAISE). // J Am Coll Cardiol. – 2003. - vol. 41(11). – p.1933–1939.64. Kalra PR, Bolger AP, Francis DP, et al. Effect of anemia on exercisetolerance in chronic heart failure in men.
// Am J Cardiol. – 2003. - vol.91(7). – p.888–89165. Westenbrink BD, Visser FW, Voors AA, et al. Anaemia in chronic heartfailure is not only related to impaired renal perfusion and bluntederythropoietin production, but to fluid retention as well. // European HeartJournal. – 2007. - vol. 28(2). – p.166–171.66. Silverberg DS, Wexler D, Iaina A, Schwartz D. The correction of anemia inpatients with the combination of chronic kidney disease and congestive heartfailure may prevent progression of both conditions.
// Clinical andExperimental Nephrology. – 2009. - vol. 13(2). – p.101–106.67. Mrug M, Stopka T, Julian BA, Prchal JF, Prchal JT. Angiotensin IIstimulates proliferation of normal early erythroid progenitors. // Journal ofClinical Investigation. – 1997. - vol. 100(9). – p.2310–231468.
Anand IS. Anemia and Chronic Heart Failure. Implications and TreatmentOptions. // Journal of the American College of Cardiology. – 2008. - vol.52(7). – p.501–511.69. Bernstein KE, Xiao HD, Frenzel K, et al. Six truisms concerning ACE andthe renin-angiotensin system educed from the genetic analysis of mice. //Circulation Research. – 2005. - vol.
96(11). – p.1135–1144.9970. Testa M, Yeh M, Lee P, et al. Circulating levels of cytokines and theirendogenous modulators in patients with mild to severe congestive heartfailure due to coronary artery disease or hypertension.
// Journal of theAmerican College of Cardiology. – 1996. - vol. 28(4). – p.964–971.71. Comnick M, Ishani A. Renal biomarkers of kidney injury in cardiorenalsyndrome. // Current Heart Failure Reports. – 2011. - vol. 8(2). – p.99–105.72. Okonko DO, Marley SB, Anker SD, Poole-Wilson PA, Gordon MY.Erythropoietin resistance contributes to anaemia in chronic heart failure andrelates to aberrant JAK-STAT signal transduction. // Int J Cardiol. 2013. vol.164(3). – p.359-64.73. Okonko DO, Marley SB, Anker SD, Poole-Wilson PA, Gordon MY.Suppression of erythropoiesis in patients with chronic heart failure andanaemia of unknown origin: evidence of an immune basis.
// Int J Cardiol. –2013. - vol.166(3). – p.664-71.74. Förstermann U, Münzel T. Endothelial nitric oxide synthase in vasculardisease: from marvel to menace. // Circulation. – 2006. - vol. 113(13). –p.1708–1714.75. Bøyum A, Fjerdingstad HB, Tennfjord VA, Benestad HB, Løvhaug D.Specific antibodies to mouse Sca-1- (Ly-6A/E) or Thy-1-positivehaematopoietic progenitor cells induce formation of nitric oxide whichinhibits subsequent colony formation. // European Journal of Haematology.– 2004.
- vol. 73(6). – p.427–430.76. Maciejewski JP, Selleri C, Sato T, et al. Nitric oxide suppression of humanhematopoiesis in vitro. Contribution to inhibitory action of interferon-γ andtumor necrosis factor-α. // Journal of Clinical Investigation. – 1995. - vol.96(2). – p.1085–1092.10077. Iversen PO, Andersson KB, Finsen AV, et al. Separate mechanisms causeanemia in ischemic vs. nonischemic murine heart failure. // AmericanJournal of Physiology, Regulatory Integrative and Comparative Physiology.– 2010.
- vol. 298(3). – p.R808–R814.78. Zittermann A, Jungvogel A, Prokop S, et al. Vitamin D deficiency is anindependent predictor of anemia in end-stage heart failure. // ClinicalResearch in Cardiology. – 2011. - vol. 100(9). – p.781–788.79. Dallalio G, Law E, Means RT. Hepcidin inhibits in vitro erythroid colonyformation at reduced erythropoietin concentrations. // Blood.
– 2006. – vol.107(7). – p.2702–2704.80. Silverberg DS, Wexler D, Iaina A, Schwartz D. Correction of irondeficiency in the cardiorenal syndrome. // International Journal ofNephrology. – 2011. - vol. 2011. – p.365301.81. Okonko DO, Mandal AKJ, Missouris CG, Poole-Wilson PA. Disorderediron homeostasis in chronic heart failure: prevalence, predictors, and relationto anemia, exercise capacity, and survival. // Journal of the AmericanCollege of Cardiology. – 2011. - vol.
58(12). – p.1241–1251.82. Stancu S, Stanciu A, Zugravu A, et al. Bone marrow iron, iron indices, andthe response to intravenous iron in patients with non-dialysis-dependentCKD. // American Journal of Kidney Diseases. – 2010. - vol. 55(4). –p.639–647.83. Weiss G, Goodnough LT. Anemia of chronic disease. // New EnglandJournal of Medicine. – 2005. - vol.352(10). – p.1011–1023.84. Naito Y, Tsujino T, Matsumoto M, Sakoda T, Ohyanagi M, Masuyama T.Adaptive response of the heart to long-term anemia induced by irondeficiency.
// American Journal of Physiology, Heart and CirculatoryPhysiology. – 2009. - vol. 296(3). – p.H585–H593.10185. Dong F, Zhang X, Culver B, Chew HG, Kelley RO, Ren J. Dietary irondeficiency induces ventricular dilation, mitochondrial ultrastructuralaberrations and cytochrome c release: involvement of nitric oxide synthaseand protein tyrosine nitration. // Clinical Science.
– 2005. - vol. 109(3). –p.277–286.86. Weiss G, Meusburger E, Radacher G, Garimorth K, Neyer U, Mayer G.Effect of iron treatment on circulating cytokine levels in ESRD patientsreceiving recombinant human erythropoietin. // Kidney International. –2003. - vol. 64(2). – p.572–578.87. Nagababu E, Gulyani S, Earley CJ, Cutler R, Mattson M, Rifkind J. Irondeficiency anaemia enhances red blood cell oxidative stress.
// Free RadicalResearch. – 2008. - vol. 42(9). – p.824–829.88. Imberti D, Giorgi Pierfranceschi M, Falciani M, Prisco D. Venousthromboembolism prevention in patients with heart failure: an oftenneglected issue. // Pathophysiology of Haemostasis and Thrombosis. – 2008.- vol. 36(2). – p.69–74.89.
Kuku I, Kaya E, Yologlu S, Gokdeniz R, Baydin A. Platelet counts in adultswith iron deficiency anemia. // Platelets. – 2009. - vol.20(6). – p.401–405.90. Streja E, Kovesdy CP, Greenland S, et al. Erythropoietin, iron depletion, andrelative thrombocytosis: a possible explanation for hemoglobin-survivalparadox in hemodialysis. // American Journal of Kidney Diseases. – 2008.
vol. 52(4). – p.727–736.91. Dahl NV, Henry DH, Coyne DW. Thrombosis with erythropoieticstimulating agents - Does iron-deficient erythropoiesis play a role? //Seminars in Dialysis. – 2008. - vol. 21(3). – p.210–211.92. Beguin Y, Loo M, R’Zik S, et al.
Effect of recombinant humanerythropoietin on platelets in patients with anemia of renal failure:102correlation of platelet count with erythropoietic activity and iron parameters.// European Journal of Haematology. – 1994. - vol. 53(5). – p.265–270.93. Silverberg DS, Wexler D, Blum M, Iaina A. The cardio renal anemiasyndrome: correcting anemia in patients with resistant congestive heartfailure can improve both cardiac and renal function and reducehospitalizations. // Clinical Nephrology.
– 2003. - vol.60 (1, supplement 1).– p.S93–S102.94. Deswal A, Petersen NJ, Feldman AM, et al. Cytokines and cytokinereceptorsin advanced heart failure: an analysis of the cytokine database fromthe Vesnarinone trial (VEST). // Circulation. – 2001. - vol. 103. – p.2055–2059.95. Fildes JE, Shaw SM, Yonan N, Williams SG. The immune system andchronic heart failure: is the heart in control? // J Am Coll Cardiol. – 2009.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
